Target intelligence / Profile preview

Strigolactone esterase DWARF14 (AtD14) (AtD14)

Target
AtD14
Molecular classification
Alpha/beta-hydrolase, Receptor, Enzyme
01

Overview

AtD14 (Strigolactone esterase DWARF14) is a primary receptor in Arabidopsis thaliana that mediates the perception of strigolactones, a class of plant hormones essential for regulating plant architecture and development (UniProt Q9SST0; Hamiaux et al., 2012). It belongs to the alpha/beta-hydrolase superfamily and functions uniquely as both a receptor and an enzyme that hydrolyzes its ligand (Yao et al., 2016). Upon binding strigolactone, AtD14 catalyzes the cleavage of the hormone, leading to the formation of a covalently linked intermediate molecule (CLIM) that triggers a significant conformational change in the protein (Zhao et al., 2013). This structural shift enables AtD14 to interact with the F-box protein MAX2 (More Axillary Growth 2), facilitating the ubiquitination and subsequent proteasomal degradation of SMXL (Suppressor of MAX2-Like) repressor proteins (Yao et al., 2016). This degradation relieves the inhibition of downstream genes, thereby controlling biological processes such as shoot branching, root growth, and the plant's response to nutrient availability (Waters et al., 2017). While AtD14 is a plant-specific protein, it is a significant target in agricultural biotechnology for the development of synthetic strigolactone analogs to manage crop architecture and combat parasitic weeds (Waters et al., 2017).

Other names
DWARF14D14At3g03990PRY2Decreased apical dominance 2 homolog
02

Mechanism of action

AtD14 acts as a covalent receptor that hydrolyzes strigolactones to form a covalent adduct, inducing a conformational change that recruits the MAX2-SCF ubiquitin ligase complex to degrade SMXL repressor proteins (Yao et al., 2016; Nature).

03

Biological functions

Signal transductionShoot branching regulationRoot developmentResponse to phosphate starvation
04

Disease associations

Plant developmental defects (dwarfism, excessive branching)Parasitic weed infestation (e.g., Striga, Orobanche)
05

Safety considerations

Off-target effects on KAI2 receptorEnvironmental persistence of synthetic analogsImpact on beneficial soil microbes (e.g., arbuscular mycorrhizal fungi)
06

Interacting drugs

GR24

3 more in the full profile.

07

Biomarkers

SMXL6 protein levelsSMXL7 protein levelsShoot branching density

Beyond the preview

Go deeper on Strigolactone esterase DWARF14 (AtD14) (AtD14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Strigolactone esterase DWARF14 (AtD14) (AtD14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call